Reports

7498 Results (Page 189 of 300)

Pharmaceuticals Markets Research Reports

Pharmaceuticals

US Kidney Cancer Drugs Market Analysis

US kidney cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising consumer awareness, technical improvements, and the appeal of kidney and renal cancer drugs goods are all contributing reasons to the market's expansion. Some of the major key players in this market are Pfizer Inc (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Rabies Vaccine Market Analysis

Vietnam Rabies Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rabies Vaccine market is growing globally due to the rising incidence of rabies, government initiatives and vaccination programs, growing pet ownership and animal healthcare realizing the importance of vaccination, technological advancements leading to more safe and effective vaccines, collaborations and partnerships between vaccine manufacturers and government bodies. Serum Institute of India Pvt. Ltd, Novartis AG, Cadila Pharmaceuticals, and Merck & Co., Inc., Sanofi, ADS Diagnostic Ltd, GSK plc, Berna Biotech Pharma GmbH, and AstraZeneca are the key global market players in rabies vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Seasonal Flu Vaccine Market Analysis

Brazil Seasonal Flu Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Seasonal Flu Vaccine market is growing globally due to the rising awareness of the necessity of getting the flu shot and the initiatives to expand immunization programmes, expanding government support and focus on seasonal flu vaccination, robust research and development activities with strong pipeline candidates, high influenza rates among children owing to demand for pediatric vaccines. GlaxoSmithKline, AstraZeneca, Seqirus, Pfizer, Novartis, Johnson & Johnson, Daiichi Sankyo Company, Bharat Biotech International Limited, Mitsubishi Tanabe Pharma Corporation are the key global market players in Seasonal flu vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Dry Eye Medication Market Analysis

China Dry Eye Medication Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of dry eye, aging population, technological advancements in drug formulations and diagnostics, rising awareness and diagnosis, and lifestyle factors such as increased screen time and air pollution are the drivers of the dry eye medication market. Allergan plc (AbbVie Inc.), Novartis AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alcon, Inc. (a division of Novartis AG), Sun Pharmaceutical Industries Ltd., Otsuka Holdings Co., Taisho Pharmaceutical Co., Ltd, Senju Pharmaceutical Co. Are global companies in Dry Eye Medication Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt NSCLC Drugs Market Analysis

Egypt NSCLC Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. During the projection period, the global non-small cell lung cancer market will grow due to the rise in cancer cases worldwide. Oral medications are predicted to accelerate market expansion. Given that the majority of medications are accessible in capsule and tablet form and that this is a very practical mode of administration, the category is anticipated to accelerate the global market.The global NSCLC Drugs market’s major key players are AstraZeneca PLC, Roche Holding AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, Novartis AG, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Johnson & Johnson.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Topical Drugs Delivery Market Analysis

France Topical Drugs Delivery Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical drugs delivery market is growing globally due to the rising incidence and prevalence of various skin disorders, such as acne, eczema, psoriasis, and dermatitis, advancements in formulation technologies like nano emulsions, liposomes, micelles, and transdermal patches, patient preference for non-invasive treatment that minimize side effects and offer localized therapy, growing aging population, rising demand for dermatological cosmetics due to focus on personal grooming, increased research and development activities and favorable regulatory environments. Johnson & Johnson Private Limited, Nestlé India Ltd., Novartis AG, GlaxoSmithKline plc, Bausch Health Companies Inc., Merck & Co Inc., Bayer AG, Hisamitsu Pharmaceutical Co.,Inc., Glenmark Pharmaceuticals Limited are the key global market players in topical drugs delivery market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market Analysis

Indonesia Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the GLP-1 receptor agonist market include their efficacy in controlling blood sugar levels, additional benefits like weight loss and cardiovascular risk reduction, rising prevalence of type 2 diabetes, and increasing awareness of diabetes management, leading to growing demand for these medications. Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH and Zealand Pharma A/S are global key players in the market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Osteoarthritis Drugs Market Analysis

Japan osteoarthritis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased prevalence of osteoarthritis, improvements in drug development R&D, increased funding from private and public organisations for the development of the healthcare sector and research centres, and increased demand for cell-based research activities are the main factors driving the growth of the osteoarthritis drugs market. Some of the major key players in this market are Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Vision Care Market Analysis

Kenya Vision Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Vision Care market is growing globally due to the increasing prevalence of eye disorders such as myopia, hyperopia, astigmatism, and age-related macular degeneration (AMD), surging volume of patients suffering from chronic diseases which will led to the occurrences of vision ailments, improper intake of nutrition and unhealthy food eating habits, technological advancements in vision care industry like innovations in lens materials, frame designs, and contact lens technologies, increasing awareness about the importance of regular eye exams and eye health initiatives by governments, healthcare organizations and growth of the e-commerce sector. EssilorLuxottica, Johnson & Johnson, Novartis AG (Alcon), CooperVision, Bausch Health Companies (Bausch + Lomb), Zeiss, Hoya Corporation, Safilo Group and Carl Zeiss Meditec are the key global market players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Hepatitis B Drugs Market Analysis

Mexico Hepatitis B Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors such as growth of pharmaceutical industry, increase in ageing population, upsurge in healthcare expenditure, urbanization leading to better monitoring and screening procedures and increase in liver cancer and cirrhosis deaths due to HBV would drive the growth of Hepatitis B drugs market. Some of the major key players in this market are Apotex Inc, Accord Healthcare, Arbutus Biopharma, Aurobindo Pharma, Arrowhead Pharmaceuticals, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences, Inc., Lupin Pharmaceuticals, Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Pharmaceutical Analytical Testing Outsourcing Market Analysis

Philippines Pharmaceutical Analytical Testing Outsourcing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical analytical testing outsourcing is growing rapidly as a result of increase in the usage of pharmaceuticals and therapeutics requiring specialized manufacturing capabilities, rise in the presence of strict regulations and requirement of pertaining to the standards provided by the authorities, growth in modernization and innovations requiring reduction of operating costs of manufacturing and development, rise in the demand for biosimilars and biopharmaceutical products as well as for analytical drugs, increase in number of products in the pipeline and rise in the improved efficiency in testing, reduced cost, quicker & reliable results and rising research and development activities in the healthcare sector. Exova, Charles River Laboratories, Boston Analytical, West Pharmaceutical Services, Inc., Dalton Pharma Services, Merck KGaA, Cambrex Corporation, WuXi AppTec, Source BioScience, Ajinomoto Bio-Pharma, Catalent, Inc., Gateway Analytical, Alcami Corporation, Aztech Sciences Inc., Recro, and AptarGroup, Inc. are few companies in Pharmaceutical Analytical Testing Outsourcing.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Autologous Matrix-induced Chondrogenesis Market Analysis

Singapore Autologous Matrix-induced Chondrogenesis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The AMIC market is driven by increasing knee injuries and cartilage defects, advancements in regenerative medicine, and the growing geriatric population. However, limited awareness and high costs are restraints. Ongoing research, collaborations, and investments are expected to address restraints and drive further advancements in the AMIC market. Key players globally in AMIC market are Geistlich Pharma AG, Arthrex, Zimmer Biomet Holdings, Smith & Nephew plc, Vericel Corporation, and B. Braun Melsungen AG, among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Inflammatory Bowel Disease (IBD) Drugs Market Analysis

South Africa Inflammatory Bowel Disease (IBD) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Numerous variables, including genetic predisposition, environmental triggers, and immune system disturbance, are to blame for the rising prevalence of ulcerative colitis and Crohn's disease. Most people who have ulcerative colitis or Crohn's disease have a family history of the condition. This will act as a driver for Inflammatory Bowel Disease (IBD) drugs market. AbbVie Inc. (U.S.) Takeda Pharmaceutical Company Limited (Tokyo) UCB S.A. (Belgium) Bausch Health Companies Inc. (Canada) Bristol-Myers Squibb Company (U.S.) Pfizer Inc. (U.S.) Celltrion Inc. (South Korea) Johnson & Johnson Services, Inc. (U.S.) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Pigments Market Analysis

Spain Pigments Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pigments market is growing globally due to the increasing demand from end use industries like paints and coatings, automotive, plastics, construction, textiles, growing construction and infrastructure development, technological advancements in pigments manufacturing like nanotechnology and availability of products on e-commerce platforms. The Chemours Company, Huntsman Corporation, Tronox Holdings plc, Sun Chemical Corporation, Clariant Corporation, LANXESS Corporation, Kronos Worldwide, Inc., PPG Industries, Inc., Ferro CorporationAmerican Colors, Inc. are the key global market players in pigments market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UK Carboprost Tromethamine Market Analysis

UK Carboprost Tromethamine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of postpartum haemorrhage, increased focus on maternal healthcare, developments in healthcare infrastructure, technological innovations in drug delivery, increasing maternal age, and supportive government initiatives are driving the carboprost tromethamine market. Pfizer Inc., Ferring Pharmaceuticals, JHP Pharmaceuticals, Hikma Pharmaceuticals, and Hemofarm A.D. are some of the leading global key competitors in the carboprost tromethamine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Knee Cartilage Repair Market Analysis

US knee cartilage repair market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Remicade Biosimilar Market Analysis

Vietnam Remicade Biosimilar Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Remicade Biosimilar market is growing globally due to the rising prevalence of autoimmune illnesses including rheumatoid arthritis, plaque psoriasis, introduction of a biosimilar version could provide financial relief for healthcare systems and increased access to essential medication for patients, quicker intravenous administration reaction times, patent expiry of branded versions will create opportunity biosimilars over other branded counterparts, thus increasing remicade biosimilar demand, growing awareness about its long-term benefits and better reimbursement scenario, technological advancements in the field of biosimilars, an increase in R&D spending by pharmaceutical companies and growing awareness about biosimilars among healthcare professionals and patients. Janssen Biotech Inc., Merck &Co., Pfizer Inc. (AC. Hospira), Celltrion Inc., Alvogen, Napp Pharmaceuticals, and Nippon Kayaku are some major players in the global Remicade (infliximab mAb) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil SGLT2 Inhibitor Market Analysis

Brazil SGLT2 Inhibitor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. SGLT2 Inhibitor market is growing globally due to the rising prevalence of type 2 diabetes, Efficacy and Safety Profile of these drugs is good in treating type 2 diabetes, promoting weight loss and protecting from cardiovascular diseases, expanded indications of these drugs to include management of heart failure with reduced ejection fraction and chronic kidney disease, advancements in drug development. Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals and Astellas are the key market players operating globally.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Encephalitis Vaccines Market Analysis

China Encephalitis Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing incidence of encephalitis, growing awareness and immunization programs, technological advancements in vaccine development, global travel and migration, and government support and funding are the drivers of the encephalitis vaccines market. GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Merck & Co., Novartis AG, Bharat Biotech International Ltd., Takeda Pharmaceutical Company Limited, Biological E. Limited, Valneva SE and Sinovac Biotech Ltd are global companies in encephalitis vaccines market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Oncology Biosimilars Market Analysis

Egypt oncology biosimilars market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased incidence of cancer is driving the global market. Furthermore, the market is expanding as more people become aware of the existence of oncology biosimilars. Additionally, the advancements in biosimilar manufacturing technologies and procedures have expanded production capacities. The major key players in this market are Sandoz International GmbH, Celltrion Inc., Pfizer Inc., Amgen Inc., Samsung Bioepis, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Topical Pain Relief Market Analysis

France Topical Pain Relief Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical Pain Relief market is growing globally due to the increase in incidence and prevalence of Chronic pain conditions such as arthritis, back pain, and musculoskeletal disorders, growing preference for non-opioid pain management due to addictive nature of opioid medications, ease of use and convenience of topical pain relief products, expanding product range and innovation, Increasing Consumer Awareness, Over-the-Counter Availability and rising healthcare expenditure. Advacare Pharma, GlaxoSmithKline Plc (GSK), Johnson & Johnson, Nestlé S.A., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi, Sun Pharmaceutical Industries Ltd are the key global market players in topical pain relief market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Glucaric Acid Market Analysis

Indonesia Glucaric Acid Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the glucaric acid market include the growing demand in various industries, driven by its applications and eco-friendly properties, increased consumer awareness of sustainability, and ongoing research and development efforts to explore new applications and production methods for glucaric acid. Global Players in Glucaric Acid Market are Rennovia Inc., Rivertop Renewables, Haihang Industry Co., Hebei Long Hai Import and Export Trade Co., Haihang Industry (Jinan) Co., Alfa Chemistry, Tokyo Chemical Industry Co., AK Scientific and Biosynth Carbosynth.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Outpatient Rehabilitation Centers Market Analysis

Japan outpatient rehabilitation centers market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. A few of the key aspects that are projected to drive growth in the global market are the rise in drug addiction instances, the prevalence of chronic diseases, advances in patient care, and rising demand for rehabilitation therapies. Some of the major key players in this market are AIM Health Group Inc., Accelerated Rehabilitation Centers, Ltd, Select Medical Holdings, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Wearable Injectors Market Analysis

Kenya Wearable Injectors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Wearable Injectors market is growing globally due to the strong healthcare infrastructure, rise in the incidence of lifestyle disorders, an ageing population that is more susceptible to diseases, increase in the desire for minimally invasive (MI) treatment alternatives, rise in chronic diseases like diabetes, autoimmune diseases, patient preference for self-administration medications in the comfort of their homes which enhances patient convenience, improves medication adherence, technological advancements in wearable injector technology which have improved device usability, functionality, patient experience. Continuous drug delivery provided by wearable injectors like more stable drug levels, reduced fluctuations, focus on patient centric care and cost-effective solutions provided by wearable injectors. Medtronic plc, Insulet Corporation, West Pharmaceutical Services, Inc., Enable Injections, SteadyMed Therapeutics, Inc., Sensile Medical AG, CeQur SA, Ypsomed AG, Becton, Dickinson and Company and Tandem Diabetes Care, Inc. are the key global market players in wearable injectors market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Hepatitis C Drugs Market Analysis

Mexico Hepatitis C drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The market will grow as a result of a number of factors, including the expansion of the pharmaceutical sector, an ageing population, growing healthcare expenditures, urbanisation, better monitoring and screening technologies, and a rise in liver cancer and cirrhosis fatalities brought on by HBV. Some of the major key players in this market are Bristol-Myers Squibb Company Gilead Sciences, Inc. Abbvie Kadmon Holdings Inc. F. Hoffmon La Roche Ltd. GlaxoSmithKline J & J Lupin Pharmaceuticals, Inc. Merck & Co., Inc. Teva Pharmaceuticals and Zydus Pharmaceuticals.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up